SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced the promotion of Amy C. Peterson, M.D., to the position of president and chief operating officer, effective immediately. Dr. Peterson has served as the company’s executive vice president and chief development officer since October 2019 and will continue to report to Sean McCarthy, D. Phil., chief executive officer and chairman of CytomX.
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.